#180: Cannabis and multiple sclerosis. Benefits, risks, CHS and what you should know

Cannabis is a popular and often emotional topic in the MS community. Some people hope it may help with spasticity, pain, sleep or other symptoms, while others are concerned about side effects, cognitive changes, dependency, high-potency THC products or complications such as cannabinoid hyperemesis syndrome, or CHS.

In this solo episode, I take a balanced look at what we currently know about cannabis and multiple sclerosis. I explain the difference between medical cannabinoid treatments such as Sativex/nabiximols, THC, CBD, recreational cannabis, edibles, concentrates and synthetic cannabinoid products. I also discuss where the evidence is strongest, where it is still uncertain, and why product type, dose and frequency matter.

The episode was inspired in part by reporting from National Geographic on CHS and modern high-potency cannabis products. I also include current MS-specific research and practical questions you can discuss with your neurologist.

In this episode

• Why cannabis is such a popular topic in the MS community
• What THC, CBD and other cannabinoids are
• Why cannabis is not one single treatment
• What Sativex/nabiximols is and where it is already used in MS
• What the evidence says about spasticity
• What we know, and do not yet know, about pain, sleep and bladder symptoms
• Why current research comparing THC and CBD is so interesting
• Why CBD should not automatically be considered an MS treatment
• Why cannabinoids do not replace disease-modifying MS therapy
• Possible effects on cognition in people with MS
• What cannabinoid hyperemesis syndrome, or CHS, is
• Why CHS can be difficult to recognize
• Why symptoms may continue for some time after stopping cannabis
• A practical CHS self-check
• Why high-potency THC products deserve special caution
• Why edibles can be difficult to dose
• The difference between prescription cannabinoids, recreational cannabis and synthetic cannabinoid receptor agonists such as K2 or Spice
• Why delta-8 THC deserves particular attention in the US
• A brief look at the legal situation in the US, Germany and other countries
• Practical questions to ask your neurologist before trying a cannabinoid-based treatment
• How to monitor whether a treatment is actually improving your quality of life

Read the full blog post

You can find the full article on: https://ms-perspektive.de/en/180-cannabis/

The blog post includes the detailed discussion behind this episode as well as the studies, reviews, official guidance and original sources used for the podcast, including research on MS spasticity, cognition, THC versus CBD, CHS and high-potency cannabis products.

Important note

This episode is intended to inform, not to promote or discourage cannabis use in general. Cannabinoid-based medicines may be helpful for some people with MS, particularly for certain symptoms, but benefits and risks depend on the exact substance, formulation, dose, frequency of use and individual situation.

Please discuss any cannabinoid-based treatment with your neurologist or another qualified healthcare professional, especially if you already take other medications or experience cognitive problems, dizziness, balance issues, recurrent nausea or vomiting.

The information in this episode does not replace individual medical advice.

---

See you soon and try to make the best out of your life,
Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.